Latest Australian Government News

Hamelin Gold reports encouraging shallow gold mineralisation at its Fremlins South prospect in Western Australia’s West Tanami, with ongoing drilling programs expanding exploration across multiple targets.

New Frontier Minerals has appointed GeoDrill Australia to lead its inaugural drilling campaign at the Harts Range Project, targeting a suite of critical minerals vital to modern technologies and energy transition.

Diatreme Resources confirms its Northern Silica Project can produce low-iron, high-purity silica sand meeting photovoltaic glass standards, backed by successful bulk metallurgical testwork. The results pave the way for final engineering and commercial deals amid a booming solar energy market.

Mayne Pharma has publicly refuted recent media claims about plans to close its Salisbury manufacturing site, clarifying its position amid ongoing regulatory scrutiny of its Scheme transaction with Cosette.

Krakatoa Resources has lodged a strategic application to expand its Mt Clere Project eastward, potentially extending its rare earth footprint by over 9km at Dingo Pass, while completing a key drilling program at Stone Tank.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Select Harvests has confirmed the presence of varroa mite in its South Australian orchard but reports no immediate impact on the 2026 almond crop. The company is working closely with authorities to contain the issue and is adjusting its bee sourcing strategy for future seasons.

5G Networks has reported a strong FY25 with an 8% revenue increase and a positive EBITDA turnaround, driven by the strategic acquisition of cyber security firm AUCyber. The company’s expansion into sovereign cloud services signals a new growth chapter.

Papyrus Australia reported a July 2025 cash flow update showing a stable cash position of AUD 303,000 and available funding supporting operations for over eight months. The company continues to manage its financing facilities prudently while navigating operational expenses.

Zelira Therapeutics reported a significantly reduced loss of AUD 3.85 million for FY25, driven by clinical progress and strategic funding for its HOPE® cannabinoid medicines. The company also expanded its patent portfolio and commercial footprint across key markets.

Radiopharm Theranostics reported a dramatic revenue surge to $3.63 million alongside a 20% reduction in net loss for FY2025, while increasing its stake in Radiopharm Ventures to 75%.

Warriedar Resources reports encouraging assay results from 20 drillholes at its Golden Range Project, confirming extensions of gold mineralisation beyond current estimates at the M1 deposit and validating historical data at Valencia.